Detection of AmpC-β-lactamases producing isolates among carbapenem resistant P. aeruginosa isolated from burn patient

  • Akbar Mirsalehian Department of Microbiology, School of Medicine, Tehran University of Medical Sciences. Tehran, Iran.
  • Davood Kalantar-Neyestanaki Department of Microbiology, School of Medicine, Tehran University of Medical Sciences. Tehran, Iran.
  • Keramat Nourijelyani Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Kheirollah Asadollahi Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
  • Morovat Taherikalani Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
  • Mohammad Emaneini Department of Microbiology, School of Medicine, Tehran University of Medical Sciences. Tehran, Iran.
  • Fereshteh Jabalameli Mail Department of Microbiology, School of Medicine, Tehran University of Medical Sciences. Tehran, Iran.
Keywords:
AmpC-β-lactamases, Pseudomonas aeruginosa, β-lactam resistance

Abstract

Background  and  Objectives: Pseudomonas  aeruginosa is responsible for devastating nosocomial infections among severely burn patients. Class C of cephalosporinase (AmpC-β-lactamases) is important cause of multiple β-lactam resistance in P. aeruginosa. The aim of this study was to detect the AmpC-β-lactamases producing isolates among carbapenem resistant P.  aeruginosa isolated from burn patient.
Material and Methods: a total of 100 isolates of carbapenem resistant P. aeruginosa isolates from different burn patients were investigated. Three phenotypic methods were selected for identification of the AmpC-β-lactamases producing isolates.
Results: Fifty four isolates were AmpC producer as detected by AmpC disk test. Seventeen isolates were identified as AmpC producer using combined disk method. Fifty two isolates showed a twofold or threefold dilution difference between the minimum inhibitory concentration of imipenem or ceftazidime and the minimum inhibitory concentration of imipenem or ceftazidime plus cloxacillin. One isolate was identified as AmpC producer using three methods. Three isolates produced AmpC as detected by both AmpC disk test and combined disk methods and 19 isolates were found as AmpC producer using both AmpC disk test and minimum inhibitory concentration methods. Six isolates were AmpC producer as shown by the MICs of both imipenem and ceftazidime.
Conclusion: According to the results of this study, AmpC- β-lactamase looks to be the main mechanism of resistance of Pseudomonas aeruginosa to cephalosporins and carbapenems in the study hospital.

References

Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009; 22: 161-82.

Thomson KS. Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues. J Clin Microbiol 2010; 48: 1019-25.

Tredget EE, Shankowsky HA, Rennie R, Burrell RE, Logsetty S. Pseudomonas infections in the thermally injured patient. Burns 2004; 30: 3-26.

Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009; 24:582-610.

Sundin S. Hidden Beta-Lactamases in the Enterobacteriaceae - dropping the extra disks for detection, Part II. Clinical Microbiology Newsletter 2009; 31: 47-52.

Jabalameli F, Mirsalehian A, Sotoudeh N, Jabalameli L, Aligholi M, Khoramian B, Taherikalani M, Emaneini M et al. Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran. Burns 2011; 37: 1202-7.

Rodríguez-Martínez M, Poirel L, Nordmann P.Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 53: 4783-87.

Khosravi AD, Mihani F. Detection of metallo-beta- lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Diagn Microbiol Infect Dis 2008; 60: 125-8.

Bahar MA, Jamali S, Samadikuchaksaraei A.Imipenem-resistant Pseudomonas aeruginosa strains carry metallo-beta-lactamase gene bla(VIM) in a level I Iranian burn hospital. Burns 2010; 36: 826-30.

Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended- spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns 2010; 36: 70-4.11. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing, Twenty- First Inform Suppl, 31, M100-S21,2011.

Song W, Hoon Jeong S, Kim JS, Kim HS, Shin DH, Roh KH, et al. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC β-Lactamase and extended-sprctrum β-Lactamase in clinical isolates off Klebsiella Spp.,Salmonella Spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 2007; 57: 315-18.

Black JA, Smith Moland E, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC β-Lactamases in Enterobacteriaceae lacking chromosomal AmpC β-Lactamases. J Clin Microbioln 2005; 43: 3110-3113.

Lee J, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo- β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents 2012;40:168–172.

Gutierrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother 2007; 51: 4329-4335.

Poole K. Pseudomonas aeruginosa: resistance to the max. Frontiers in Microbiology 2011; 2: 65.

How to Cite
1.
Mirsalehian A, Kalantar-Neyestanaki D, Nourijelyani K, Asadollahi K, Taherikalani M, Emaneini M, Jabalameli F. Detection of AmpC-β-lactamases producing isolates among carbapenem resistant P. aeruginosa isolated from burn patient. Iran J Microbiol. 6(5):306-310.
Section
Articles